Level Zero Health, a female-founded medical device startup that's aiming to break new ground by developing a device for ...
A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the ...
Septerna (SEPN) announced its decision to discontinue the Phase 1 single- and multiple-ascending dose clinical trial of SEP-786 in healthy ...
See, researchers have discovered that the annoying cravings we often get for sweets—even when we’re full already—are a ...
Finnish researchers show in a new study that pituitary macrophages, the immune cells located in the pituitary gland, help ...
Much like all biases based on hormones, the rules that exclude transgender people in sports are based on little to no ...
Trump's executive order "seems to deny that this population even exists, or deserves to exist,” Judge Brendan Hurson said.
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
Newly elected Republican Pennsylvania Attorney General David Sunday has not taken action to support President Trump’s ...
Before stopping in response to President Donald Trump’s order canceling federal funding for child sex changes, six ...
The agency's warning applies to a growing field of wearable devices that track patients’ sugar levels or automatically ...
That stress can lead to high levels of stress hormones like cortisol and epinephrine, which ultimately cause rises in blood sugar. There’s not much research yet on the value of tracking blood ...